<div id="readability-page-1"><p>Handelsbanken Fonder AB raised its stake in shares of  HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 7.9% in the fourth quarter, according to its most recent filing with the Securities &amp; Exchange Commission. The institutional investor  owned 213,272 shares of the company's stock after buying an additional 15,675 shares during the quarter. Handelsbanken Fonder AB owned about 0.09% of HCA Healthcare worth $99,568,000 at the end of the most recent reporting period.</p><div><p><span></span><span>Get <strong>HCA Healthcare</strong> alerts:</span></p></div><ul><li>The Aging of America Could Make HCA Healthcare a Long-Term Winner</li></ul><p>Other hedge funds have also added to or reduced their stakes in the company. Holos Integrated Wealth LLC purchased a new position in  HCA Healthcare during the 4th quarter valued at about $29,000.  Palisade Asset Management LLC bought a new stake in shares of  HCA Healthcare during the 3rd quarter valued at about $26,000.  Ares Financial Consulting LLC bought a new stake in shares of  HCA Healthcare during the 4th quarter valued at about $31,000.  Aventura Private Wealth LLC bought a new stake in shares of  HCA Healthcare during the 4th quarter valued at about $34,000.  Finally, Key Capital Management INC bought a new stake in shares of  HCA Healthcare during the 4th quarter valued at about $35,000. Hedge funds and other institutional investors own  62.73% of the company's stock. </p><h2>HCA Healthcare Stock Performance</h2><p>Shares of HCA stock opened at $422.60 on Tuesday. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52. The stock has a 50 day moving average price of $476.49 and a two-hundred day moving average price of $485.66. The company has a market capitalization of $93.75 billion, a P/E ratio of 14.53, a PEG ratio of 1.34 and a beta of 1.18. </p><ul><li>This ETF Is Proof That the Healthcare Rebound Is Real</li></ul><p>HCA Healthcare (NYSE:HCA - Get Free Report) last announced its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The company had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. During the same quarter in the previous year, the firm posted $6.45 EPS. The business's revenue for the quarter was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS.  As a group, equities analysts predict that  HCA Healthcare, Inc. will post 30.07 earnings per share for the current year. </p><h2>HCA Healthcare Dividend Announcement</h2><p>The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be given a $0.78 dividend. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.7%. HCA Healthcare's payout ratio is presently 10.73%. </p><h2>Insider Activity</h2><ul><li>MarketBeat Week in Review – 07/28 - 08/01</li></ul><p>In other news, EVP Michael R. Mcalevey sold 1,694 shares of the business's stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total transaction of $903,528.78. Following the transaction, the executive vice president directly owned 8,853 shares of the company's stock, valued at approximately $4,721,924.61. The trade was a 16.06% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which is accessible through this hyperlink. Company insiders own  1.50% of the company's stock. </p><h2>Analyst Ratings Changes</h2><p>HCA has been the subject of a number of research analyst reports. UBS Group lifted their price target on HCA Healthcare from $598.00 to $635.00 and gave the company a &#34;buy&#34; rating in a research report on Monday, February 23rd. The Goldman Sachs Group lifted their price target on HCA Healthcare from $520.00 to $558.00 and gave the company a &#34;buy&#34; rating in a research report on Wednesday, January 28th. TD Cowen dropped their target price on HCA Healthcare from $561.00 to $500.00 and set a &#34;buy&#34; rating for the company in a research report on Monday, April 27th. Jefferies Financial Group  restated a &#34;buy&#34; rating and issued a $525.00 target price on shares of HCA Healthcare in a research report on Friday, April 24th. Finally, Royal Bank Of Canada dropped their target price on HCA Healthcare from $593.00 to $534.00 and set an &#34;outperform&#34; rating for the company in a research report on Monday, April 27th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have assigned  a Hold rating and one  has issued  a Sell rating to the company's stock. According to MarketBeat, HCA Healthcare currently has an average rating of &#34;Moderate Buy&#34; and an average target price of $517.82.</p><p><b>Read Our Latest Research Report on HCA Healthcare</b></p><h2>HCA Healthcare Profile</h2> (Free Report)<p>HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.  </p><p>The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.</p><h2>See Also</h2><ul><li>Five stocks we like better than HCA Healthcare</li><li>Why Applied Optoelectronics Stock May Be Near a Turning Point</li><li>From High-Yield to High-Growth: 3 Stocks Boosting Dividends</li><li>Is Everspin Technologies the Next AI Edge Breakout?</li><li>5 Robotics Stocks to Watch as Physical AI Builds Momentum</li></ul><p><strong>Want to see what other hedge funds are holding HCA?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUhDQQ"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in HCA Healthcare Right Now?</h2><p>Before you consider HCA Healthcare, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.</p><p>While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Handelsbanken Fonder AB increased its stake in HCA Healthcare, Inc. by 7.9% in Q4, owning 213,272 shares valued at approximately $99.57 million. Other hedge funds also adjusted their positions. HCA's stock opened at $422.60, with a market cap of $93.75 billion. The company reported Q1 earnings of $7.15 per share, slightly below estimates, and announced a quarterly dividend of $0.78. Analysts have varied price targets, with UBS raising theirs to $635.00.</p>

Market Beat

HCA Healthcare

Health Care Select Sector SPDR

iShares US Healthcare Providers

VG Health

SPDR S&P Health

iShares Global Healthcare

UBS Group AG

Goldman Sachs

Toronto Dominion Bank

Jefferies Financial

ROYAL BANK OF CANADA

GS Hldg R

Handelsbanken Fonder AB Boosts Position in HCA Healthcare, Inc. $HCA